C.D.C. Panel Meet for Debate on Whether to Advise Pfizer Boosters for Children 5 to 11
Although the F.D.A. authorized the shots this week, hesitancy is high. Fewer than one-third of children in this age group have received two doses.
Source: NYT Health - Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Children and Childhood Pfizer Inc BioNTech SE Centers for Disease Control and Prevention United States Source Type: news
More News: Centers for Disease Control and Prevention (CDC) | Children | Coronavirus | Covid Vaccine | COVID-19 | Health | Pfizer | USA Health | Vaccines